{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:25:12Z","timestamp":1786951512809,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10735-026-10877-1","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:35:54Z","timestamp":1782714954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stigmasterol glucoside attenuates RANKL-induced osteoclastogenesis and bone resorption by suppressing MAPK and STAT3 signaling pathways: an integrative pharmacological study"],"prefix":"10.1007","volume":"57","author":[{"given":"Yiwei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maihuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1604-330X","authenticated-orcid":false,"given":"Zhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"10877_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jbmr.2708","volume":"31","author":"RA Adler","year":"2016","unstructured":"Adler RA, El-Hajj Fuleihan G, Bauer DC et al (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American society for bone and mineral research. J Bone Min Res 31:16\u201335. https:\/\/doi.org\/10.1002\/jbmr.2708","journal-title":"J Bone Min Res"},{"key":"10877_CR2","doi-asserted-by":"publisher","first-page":"116297","DOI":"10.1016\/j.bone.2021.116297","volume":"156","author":"DM Black","year":"2022","unstructured":"Black DM, Condra K, Adams AL, Eastell R (2022) Bisphosphonates and the risk of atypical femur fractures. Bone 156:116297. https:\/\/doi.org\/10.1016\/j.bone.2021.116297","journal-title":"Bone"},{"key":"10877_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1177\/0022034513500306","volume":"92","author":"BF Boyce","year":"2013","unstructured":"Boyce BF (2013) Advances in the regulation of osteoclasts and osteoclast functions. J Dent Res 92:860\u2013867. https:\/\/doi.org\/10.1177\/0022034513500306","journal-title":"J Dent Res"},{"key":"10877_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/03008207.2017.1290085","volume":"59","author":"X Chen","year":"2018","unstructured":"Chen X, Wang Z, Duan N et al (2018) Osteoblast\u2013osteoclast interactions. Connect Tissue Res 59:99\u2013107. https:\/\/doi.org\/10.1080\/03008207.2017.1290085","journal-title":"Connect Tissue Res"},{"key":"10877_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD (2019) Osteoporos Lancet 393:364\u2013376. https:\/\/doi.org\/10.1016\/S0140-6736(18)32112-3","journal-title":"Osteoporos Lancet"},{"key":"10877_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.gene.2005.12.012","volume":"372","author":"TN Crotti","year":"2006","unstructured":"Crotti TN, Flannery M, Walsh NC et al (2006) NFATc1 regulation of the human \u03b23 integrin promoter in osteoclast differentiation. Gene 372:92\u2013102. https:\/\/doi.org\/10.1016\/j.gene.2005.12.012","journal-title":"Gene"},{"key":"10877_CR7","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.7150\/thno.28391","volume":"8","author":"X Duan","year":"2018","unstructured":"Duan X, Yang S, Zhang L, Yang T (2018) V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis. Theranostics 8:5379\u20135399. https:\/\/doi.org\/10.7150\/thno.28391","journal-title":"Theranostics"},{"key":"10877_CR8","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","volume":"2","author":"R Eastell","year":"2016","unstructured":"Eastell R, O\u2019Neill TW, Hofbauer LC et al (2016) Postmenopausal osteoporosis. Nat Rev Dis Primers 2:16069. https:\/\/doi.org\/10.1038\/nrdp.2016.69","journal-title":"Nat Rev Dis Primers"},{"key":"10877_CR9","doi-asserted-by":"publisher","first-page":"132742","DOI":"10.1016\/j.foodchem.2022.132742","volume":"387","author":"S Feng","year":"2022","unstructured":"Feng S, Wang L, Shao P et al (2022) Simultaneous analysis of free phytosterols and phytosterol glycosides in rice bran by SPE\/GC\u2013MS. Food Chem 387:132742. https:\/\/doi.org\/10.1016\/j.foodchem.2022.132742","journal-title":"Food Chem"},{"key":"10877_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2021.05.014","volume":"123","author":"V Fischer","year":"2022","unstructured":"Fischer V, Haffner-Luntzer M (2022) Interaction between bone and immune cells: implications for postmenopausal osteoporosis. Semin Cell Dev Biol 123:14\u201321. https:\/\/doi.org\/10.1016\/j.semcdb.2021.05.014","journal-title":"Semin Cell Dev Biol"},{"key":"10877_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.plipres.2010.02.001","volume":"49","author":"S Grille","year":"2010","unstructured":"Grille S, Zaslawski A, Thiele S et al (2010) The functions of steryl glycosides come to those who wait: recent advances in plants, fungi, bacteria and animals. Prog Lipid Res 49:262\u2013288. https:\/\/doi.org\/10.1016\/j.plipres.2010.02.001","journal-title":"Prog Lipid Res"},{"key":"10877_CR12","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/ijms22031329","volume":"22","author":"C Heinemann","year":"2021","unstructured":"Heinemann C, Adam J, Kruppke B et al (2021) How to get them off?\u2014assessment of innovative techniques for generation and detachment of mature osteoclasts for biomaterial resorption studies. Int J Mol Sci 22:1329. https:\/\/doi.org\/10.3390\/ijms22031329","journal-title":"Int J Mol Sci"},{"key":"10877_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbrc.2006.10.011","volume":"351","author":"H Huang","year":"2006","unstructured":"Huang H, Chang E-J, Ryu J et al (2006a) Induction of c-fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem Biophys Res Commun 351:99\u2013105. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.011","journal-title":"Biochem Biophys Res Commun"},{"key":"10877_CR14","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/sj.cdd.4401882","volume":"13","author":"H Huang","year":"2006","unstructured":"Huang H, Ryu J, Ha J et al (2006b) Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-\u03baB transactivation by RANKL. Cell Death Differ 13:1879\u20131891. https:\/\/doi.org\/10.1038\/sj.cdd.4401882","journal-title":"Cell Death Differ"},{"key":"10877_CR15","doi-asserted-by":"publisher","unstructured":"Huang W, Liu T, Liao J et al (2026) \u03b2 -sitosterol suppresses osteoclastogenesis and alleviates bone loss by targeting Tmed10 to inhibit RANKL -induced hedgehog\/ MAPK signaling and ROS. Phytother Res ptr 70263. https:\/\/doi.org\/10.1002\/ptr.70263","DOI":"10.1002\/ptr.70263"},{"key":"10877_CR16","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1021\/np500417d","volume":"77","author":"J-E Huh","year":"2014","unstructured":"Huh J-E, Lee WI, Kang JW et al (2014) Formononetin attenuates osteoclastogenesis via suppressing the RANKL-induced activation of NF-\u03baB, c-fos, and nuclear factor of activated T-cells cytoplasmic 1 signaling pathway. J Nat Prod 77:2423\u20132431. https:\/\/doi.org\/10.1021\/np500417d","journal-title":"J Nat Prod"},{"key":"10877_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","volume":"21","author":"JH Kim","year":"2014","unstructured":"Kim JH, Kim N (2014) Regulation of NFATc1 in osteoclast differentiation. J Bone Metab 21:233\u2013242. https:\/\/doi.org\/10.11005\/jbm.2014.21.4.233","journal-title":"J Bone Metab"},{"key":"10877_CR18","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.4049\/jimmunol.178.9.5588","volume":"178","author":"K Kim","year":"2007","unstructured":"Kim K, Lee J, Kim JH et al (2007) Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor. J Immunol 178:5588\u20135594. https:\/\/doi.org\/10.4049\/jimmunol.178.9.5588","journal-title":"J Immunol"},{"key":"10877_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1210\/me.2007-0237","volume":"22","author":"K Kim","year":"2008","unstructured":"Kim K, Lee S-H, Ha Kim J et al (2008) NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 22:176\u2013185. https:\/\/doi.org\/10.1210\/me.2007-0237","journal-title":"Mol Endocrinol"},{"key":"10877_CR20","doi-asserted-by":"publisher","first-page":"116166","DOI":"10.1016\/j.biopha.2024.116166","volume":"171","author":"H Li","year":"2024","unstructured":"Li H, Deng W, Yang J et al (2024) Corylifol a suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via attenuating ROS production and impairing mitochondrial function. Biomed Pharmacother 171:116166. https:\/\/doi.org\/10.1016\/j.biopha.2024.116166","journal-title":"Biomed Pharmacother"},{"key":"10877_CR22","doi-asserted-by":"publisher","first-page":"176604","DOI":"10.1016\/j.ejphar.2024.176604","volume":"974","author":"R Liu","year":"2024","unstructured":"Liu R, Xu L-X, Tong L-J et al (2024) Therapeutic effects of ginsenosides on osteoporosis for novel drug applications. Eur J Pharmacol 974:176604. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176604","journal-title":"Eur J Pharmacol"},{"key":"10877_CR21","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/ptr.70221","volume":"40","author":"L Liu","year":"2026","unstructured":"Liu L, Si K, Gu Y et al (2026) Stigmasterol glucoside, a phytosterol glycoside, mitigates systemic inflammatory response syndrome and liver injury. Phytother Res 40:1217\u20131229. https:\/\/doi.org\/10.1002\/ptr.70221","journal-title":"Phytother Res"},{"key":"10877_CR23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s11914-023-00805-7","volume":"21","author":"JC Lo","year":"2023","unstructured":"Lo JC, Yang W, Park-Sigal JJ, Ott SM (2023) Osteoporosis and fracture risk among older US asian adults. Curr Osteoporos Rep 21:592\u2013608. https:\/\/doi.org\/10.1007\/s11914-023-00805-7","journal-title":"Curr Osteoporos Rep"},{"key":"10877_CR24","doi-asserted-by":"publisher","unstructured":"Madel M-B, Ib\u00e1\u00f1ez L, Rouleau M et al (2018) A novel reliable and efficient procedure for purification of mature osteoclasts allowing functional assays in mouse cells. Front Immunol 9. https:\/\/doi.org\/10.3389\/fimmu.2018.02567","DOI":"10.3389\/fimmu.2018.02567"},{"key":"10877_CR25","doi-asserted-by":"publisher","first-page":"1683279","DOI":"10.3389\/fphar.2025.1683279","volume":"16","author":"X Ouyang","year":"2025","unstructured":"Ouyang X, Ma Q, Zhou C et al (2025) Natural bioactive products in the regulation of bone metabolism and regeneration. Front Pharmacol 16:1683279. https:\/\/doi.org\/10.3389\/fphar.2025.1683279","journal-title":"Front Pharmacol"},{"key":"10877_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.biopha.2017.01.068","volume":"88","author":"N Shahzad","year":"2017","unstructured":"Shahzad N, Khan W, Md S et al (2017) Phytosterols as a natural anticancer agent: current status and future perspective. Biomed Pharmacother 88:786\u2013794. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.068","journal-title":"Biomed Pharmacother"},{"key":"10877_CR27","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/ijms19040984","volume":"19","author":"J Takito","year":"2018","unstructured":"Takito J, Inoue S, Nakamura M (2018) The sealing zone in osteoclasts: a self-organized structure on the bone. Int J Mol Sci 19:984. https:\/\/doi.org\/10.3390\/ijms19040984","journal-title":"Int J Mol Sci"},{"key":"10877_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL\u2013RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17\u201325. https:\/\/doi.org\/10.1016\/j.molmed.2005.11.007","journal-title":"Trends Mol Med"},{"key":"10877_CR29","doi-asserted-by":"publisher","first-page":"15395","DOI":"10.1074\/jbc.RA119.010139","volume":"294","author":"Y Yang","year":"2019","unstructured":"Yang Y, Chung MR, Zhou S et al (2019) STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription. J Biol Chem 294:15395\u201315407. https:\/\/doi.org\/10.1074\/jbc.RA119.010139","journal-title":"J Biol Chem"},{"key":"10877_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M Zaidi","year":"2007","unstructured":"Zaidi M (2007) Skeletal remodeling in health and disease. Nat Med 13:791\u2013801. https:\/\/doi.org\/10.1038\/nm1593","journal-title":"Nat Med"},{"key":"10877_CR31","doi-asserted-by":"publisher","first-page":"1527494","DOI":"10.3389\/fphar.2024.1527494","volume":"15","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Chen X, Mai B et al (2024) Stigmasterol mitigates estrogen-deficiency-induced osteoporosis through inhibition of phosphorylated p65 and MAPK signaling pathways. Front Pharmacol 15:1527494. https:\/\/doi.org\/10.3389\/fphar.2024.1527494","journal-title":"Front Pharmacol"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10877-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10877-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10877-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:49:25Z","timestamp":1786949365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10877-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10877"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10877-1","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"211"}}